Modulation of normal human eosinophil chemotaxis in vitro by herbimycin A, erbstatin and pervanadate

International Archives of Allergy and Immunology

Volumn 117, Issue SUPPL. 1, 1998, Pages 10-13

  El Shazly, Amr ^a   Masuyama, Keisuke ^a   Eura, Masao ^a   Ishikawa, Takeru ^a  

^a KUMAMOTO UNIVERSITY   (Japan)

Author keywords

Chemotaxis; Eosinophil; Eotaxin; Erbstatin; Herbimycin A; Modulation; PAF; Pervanadate; VIP

Indexed keywords

EOSINOPHIL CHEMOTACTIC FACTOR; EOTAXIN; ERBSTATIN; HERBIMYCIN A; PERVANADATE; PROTEIN TYROSINE KINASE; PROTEIN TYROSINE KINASE INHIBITOR; PROTEIN TYROSINE PHOSPHATASE; PROTEIN TYROSINE PHOSPHATASE INHIBITOR; THROMBOCYTE ACTIVATING FACTOR; VASOACTIVE INTESTINAL POLYPEPTIDE;

CHEMOTAXIS; CONFERENCE PAPER; CONTROLLED STUDY; ENZYME ACTIVITY; EOSINOPHIL; HUMAN; HUMAN CELL; NORMAL HUMAN; PRIORITY JOURNAL;

BENZOQUINONES; CHEMOKINES, CC; CHEMOTACTIC FACTORS, EOSINOPHIL; CHEMOTAXIS, LEUKOCYTE; CYTOKINES; ENZYME INHIBITORS; EOSINOPHILS; HUMANS; HYDROQUINONES; LACTAMS, MACROCYCLIC; PLATELET ACTIVATING FACTOR; PROTEIN-TYROSINE KINASES; PROTEIN-TYROSINE-PHOSPHATASE; QUINONES; VANADATES; VASOACTIVE INTESTINAL PEPTIDE;

EID: 0031696249     PISSN: 10182438     EISSN: None     Source Type: Journal    
DOI: 10.1159/000053563     Document Type: Conference Paper

References (13)

1. Gleich GJ, Flavahan NA, Fujisawa T, Vanhoutt PM: The eosinophil as a mediator of damage to respiratory epithelium: A model for bronchial hyperactivity. J Allergy Clin Immunol 1988;81: 776 781.
2. Venge P, Hakansson L, Peterson CGB: Eosinophils activation in allergic disease. Int Arch Allergy Appl Immunol 1987;82:333-337.
3. Fukuda T, Gleich GJ: Heterogeneity of human eosinophils. J Allergy Clin Immunol 1989;83: 369 372.
4. Gomez-Cambronero J, Huang CH, Bonak VA, Wang E, Casnellie JE, Shiraishi T, Sha'afi RI: Tyrosine phosphorylation in human neutrophils. Biochem Biophys Res Commun 1989;162: 1478-1485.
5. Naccahe PH, Gilbert C, Caon AC, Gaudry M, Huang CK, Bonak VA, Umezawa K, McColl SR: Selective inhibition of human neutrophil functional responsiveness by erbstatin, an inhibitor of tyrosine protein kinase. Blood 1990;76: 2098 2104.
6. Kusonoki T, Higashi H, Hosoi S, Hata D, Sugie K, Mayumi M, Mikawa H: Tyrosine phosphorylation and its possible role in Superoxide production by human neutrophils stimulated with FMLP and IgG. Biochem biophys Res Commun 1992;183:789 796.
7. Yasui K, Yamazaki M, Miyabayashi M, Tsuno T, Komiyama A: Signal transduction pathway in human polymorphonuclear leukocytes for chemotaxis induced by a chemotactic factor. J Immunol 1994;152:5922-5929.
8. Umezawa H, Imoto M, Sawa T, Isshiki K, Matsuda N, Uchida T, Iinuma H, Hamada M, Takeuchi T: Studies on a new epidermal growth factor-receptor kinase inhibitor, erbstatin, produced by MH435-hF3. J Antibiot (Tokyo) 1986;39:170-173.
9. Uehara Y, Fukazawa H: Use and selectivity of herbimycin A as inhibitor of protein tyrosine kinases. Methods Enzymol 1991;201:370-379.
10. 2 and vanadate stimulate protein tyrosine phosphorylation in intact cells. J Biol Chem 1990;265:2896 2902.
11. Hansel TT, De Vries IJ, Iff T, Rihs S, Wandzilak M, Beiz S, Blaser K, Walker C: An improved immunomagnetic procedure for the isolation of highly purified human blood eosinophils. J Immunol Methods 1991;145:105-110.
12. van ToI V, Verspaget HW, Pena AS, Jansen JB, Aparicio-Pages MN, Lamers CB: Modulatory effects of VIP and related peptides from the gastrointestinal tract on cell mediated cytotoxicity against tumour cells in vitro. Immunol Invest 1991;20:257-267.
13. Kroegel C, Matthys H: Platelet-activating factor-induced human eosinophil activation: generation and release of cyclooxygenase metabolites in human blood eosinophils from asthmatics. Immunology 1993;78:279 285.